Replies to post #30792 on RespireRx Pharmaceuticals Inc (fka RSPI)

[tonyvanw]

If I read the third quarter report correctly, it looks like the 3Q cash burn was approximately $1.5 Million. 9/30 cash of $1.1 Million and 9/30 accounts payable/accrued expenses of $1.9 Million. This suggests that they are currently running on fumes.